Major Companies in the Vietnam Autoimmune Disease Market | Insights & Key Players 2026

Major Companies in the Vietnam Autoimmune Disease Market

The Vietnam autoimmune disease market is influenced by a blend of established global biopharmaceutical giants and specialized manufacturers focused on immunology and chronic inflammatory treatments. These companies have maintained a lead in the market due to their knowledge in biological therapies, and patient support programs. The key players in the market include AbbVie Vietnam, Roche Vietnam, Novartis Vietnam, Pfizer Vietnam, Johnson & Johnson (Janssen), Sanofi Vietnam, Eli Lilly Vietnam, Bristol Myers Squibb, Amgen Vietnam, and Teva Pharmaceuticals.

Vietnam Autoimmune Disease Market Overview

According to 6Wresearch, the Vietnam autoimmune disease market is poised for stable growth, driven by an increased demand from a rising patient population and the expansion of private healthcare facilities offering specialized infusions. The market is expanding due to a surge in medical interventions, especially in the rheumatology and gastroenterology sectors involving the treatment of rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Additionally, this is a major segment for a number of companies that specialize in monoclonal antibodies and their biosimilar alternatives.

Competitive Landscape

The competitive landscape of the Vietnam autoimmune disease industry is formed by renowned giants and local distributors striving for a large market share in the immunology and specialized pharmacy sectors. Simultaneously, companies are focusing on quality control, innovation of cytokine-targeting therapies, and adhering to global safety requirements. These players sustain their presence by continuously improving their clinical trial accessibility, and ensuring long-term drug efficacy.

Below is a list of leading players operating in the Vietnam Autoimmune Disease Market:

1. AbbVie Vietnam

AbbVie is a global leader in immunology, widely recognized for its portfolio of biologic treatments for rheumatoid arthritis and Crohn's disease.

2. Roche Vietnam

Roche is a pioneer in biotechnology, known for its targeted therapies in rheumatology and its advanced diagnostic solutions.

3. Novartis Vietnam

Novartis is a major medical giant providing a wide range of immunology solutions, including treatments for psoriasis and ankylosing spondylitis.

4. Pfizer Vietnam

Pfizer is a prominent global manufacturer that supplies specialized JAK inhibitors and biosimilars for various inflammatory conditions.

5. Johnson & Johnson (Janssen)

Janssen, the pharmaceutical arm of J&J, is a leading provider of high-quality immunology products.

6. Sanofi Vietnam

Sanofi is a leading manufacturer in specialty care, offering advanced treatments designed for type 1 diabetes and dermatological autoimmune conditions.

7. Eli Lilly Vietnam

Eli Lilly focuses on providing innovative therapies for autoimmune disorders, including advanced treatments for rheumatoid arthritis and plaque psoriasis.

8. Bristol Myers Squibb

Bristol Myers Squibb is a major innovator that provides comprehensive immunology solutions focused on T-cell stimulation modulation.

9. Amgen Vietnam

Amgen manages a significant portfolio of biological products and biosimilars essential for treating chronic inflammatory diseases.

10. Teva Pharmaceuticals

Teva is a global leader in both generic and specialty medicines, supplying critical therapies for multiple sclerosis.

Major Companies in the Vietnam Autoimmune Disease Market: FAQs